{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:55:33Z","timestamp":1773842133261,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274003"],"award-info":[{"award-number":["82274003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008092","name":"Jinhua City Science and Technology Bureau","doi-asserted-by":"publisher","award":["2023-1-119"],"award-info":[{"award-number":["2023-1-119"]}],"id":[{"id":"10.13039\/501100008092","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jpba.2025.117266","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:27:57Z","timestamp":1763630877000},"page":"117266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development of a UHPLC-MS\/MS method for the quantification of DMPC and DMPG in rats and its pharmacokinetic and tissue distribution application"],"prefix":"10.1016","volume":"269","author":[{"given":"Zheming","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengting","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debo","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lushan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jpba.2025.117266_bib1","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1016\/j.apsb.2023.05.018","article-title":"Current research trends of nanomedicines","volume":"13","author":"Liu","year":"2023","journal-title":"Acta Pharm. Sin. B."},{"issue":"2","key":"10.1016\/j.jpba.2025.117266_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/0122117385324246240826042254","article-title":"Recent advancements in nanopharmaceuticals for novel drug delivery systems","volume":"13","author":"Liew","year":"2025","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.jpba.2025.117266_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115751","article-title":"Liposomes characterization for market approval as pharmaceutical products: analytical methods, guidelines and standardized protocols","volume":"236","author":"Giordani","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117266_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bmt.2023.09.001","article-title":"Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment","volume":"5","author":"Elumalai","year":"2024","journal-title":"Biomed. Technol."},{"issue":"15","key":"10.1016\/j.jpba.2025.117266_bib5","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s40265-018-0989-0","article-title":"Caplacizumab: first global approval","volume":"78","author":"Duggan","year":"2018","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jpba.2025.117266_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40005-022-00607-6","article-title":"Nanomedicine-based commercial formulations: current developments and future prospects","volume":"53","author":"Thapa","year":"2023","journal-title":"J. Pharm. Invest."},{"issue":"7","key":"10.1016\/j.jpba.2025.117266_bib7","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.apsb.2022.02.025","article-title":"Current approaches of nanomedicines in the market and various stage of clinical translation","volume":"12","author":"Shan","year":"2022","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.jpba.2025.117266_bib8","article-title":"Sustainable technologies for liposome preparation","volume":"165","author":"Leitgeb","year":"2020","journal-title":"J. Supercrit. Fluids"},{"key":"10.1016\/j.jpba.2025.117266_bib9","unstructured":"Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA). the Technical Guidelines for Nonclinical Pharmacokinetic Studies of Nanomedicines. \u3008https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/95945bb17a7dcde7b68638525ed38f66\u3009. 2021 (accessed 1 Jun 2025)."},{"key":"10.1016\/j.jpba.2025.117266_bib10","unstructured":"U.S. Food and Drug Administration. Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation, Guidance for Industry. 2018 (accessed 6 Oct 2025)."},{"key":"10.1016\/j.jpba.2025.117266_bib11","unstructured":"European Medicines Agency. Reflection paper on the data requirements for intravenous liposomal products developed with reference to an innovator liposomal product. 2013 (accessed 6 Oct 2025)."},{"key":"10.1016\/j.jpba.2025.117266_bib12","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). M3(R2) Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals. (2009)."},{"key":"10.1016\/j.jpba.2025.117266_bib13","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). S3A Note for Guidance on Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies. (1994)."},{"issue":"4","key":"10.1016\/j.jpba.2025.117266_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1039\/D2TB02001G","article-title":"Physicochemical properties, pharmacokinetics, toxicology and application of nanocarriers","volume":"11","author":"Cai","year":"2023","journal-title":"J. Mater. Chem. B."},{"issue":"5","key":"10.1016\/j.jpba.2025.117266_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5603","article-title":"Preparation, characterization, and pharmacokinetics oforidonin-loaded liposomes","volume":"37","author":"Lin","year":"2023","journal-title":"Biomed. Chromatogr."},{"issue":"7","key":"10.1016\/j.jpba.2025.117266_bib16","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3390\/pharmaceutics15071951","article-title":"Systemic protein delivery via inhalable liposomes: formulation and pharmacokinetics","volume":"15","author":"Ponkshe","year":"2023","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.jpba.2025.117266_bib17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1447-0756.1996.tb01061.x","article-title":"A method of measuring dipalmitoylphosphatidylcholine (DPPC) by high-performance liquid chromatography (HPLC): effect of dexamethasone on DPPC secretion in fetal rat alveolar type I1 cell","volume":"22","author":"Suzuki","year":"1996","journal-title":"Cult. J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.jpba.2025.117266_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115011","article-title":"A rapid and quantitative reversed-phase HPLC-DAD\/ELSD method for lipids involved in nanoparticle formulations","volume":"220","author":"Mousli","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117266_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114473","article-title":"Analysis of verteporfin liposomal formulations for phospholipids and phospholipid degradation products by liquid chromatography-mass spectrometry (LC-MS)","volume":"208","author":"Ansar","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117266_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jpba.2018.06.014","article-title":"Bioanalysis of free and liposomal Amphotericin B in rat plasma using solid phase extraction and protein precipitation followed by LC-MS\/MS","volume":"158","author":"Su","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117266_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113104","article-title":"The simultaneous quantification of phytosterols and tocopherols in liposomal formulations using validated atmospheric pressure chemical ionization- liquid chromatography \u2013tandem mass spectrometry","volume":"183","author":"Poudel","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.jpba.2025.117266_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1179\/acb.2002.014","article-title":"The amphotericin B lipid complex or Abelcet: its Belgian connection, its mode of action and specificity: a review","volume":"57","author":"Trouet","year":"2002","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.jpba.2025.117266_bib23","unstructured":"Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China (2020 Edition, Vol. IV). Beijing: China Medicine Science and Technology Press. General Chapter 9012: Guidelines for Bioanalytical Method Validation."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525006077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525006077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:46:01Z","timestamp":1773827161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525006077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":23,"alternative-id":["S0731708525006077"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117266","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a UHPLC-MS\/MS method for the quantification of DMPC and DMPG in rats and its pharmacokinetic and tissue distribution application","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117266"}}